MedPath

Pentavac

Registration Number: MAL16045064AZ

Approved
Approval ID

698c65ec495c54c0

Registration Number

MAL16045064AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

50vial VialsAvailable
Package Size: 50vial Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Diphtheria ToxoidActive
Monograph: 白喉类毒素
Haemophilus Influenza Type b ConjugateActive
Monograph: haemophilus influenza type b conjugate
hepatitis B, purified antigenActive
Monograph: hepatitis b, purified antigen
Tetanus ToxoidActive
Bulk Pertussis VaccineActive
Monograph: bulk pertussis vaccine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pentavac - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform